Downloads: 631

Files in This Item:
File Description SizeFormat 
j.crohns.2012.12.003.pdf276.34 kBAdobe PDFView/Open
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFukuchi, Takumien
dc.contributor.authorNakase, Hiroshien
dc.contributor.authorMatsuura, Minoruen
dc.contributor.authorYoshino, Takuyaen
dc.contributor.authorToyonaga, Takahikoen
dc.contributor.authorOhmori, Katsuyukien
dc.contributor.authorUbukata, Satoshien
dc.contributor.authorUeda, Ayaen
dc.contributor.authorEguchi, Takaakien
dc.contributor.authorYamashita, Hiroshien
dc.contributor.authorIto, Daien
dc.contributor.authorAshida, Kiyoshien
dc.contributor.alternative仲瀬, 裕志ja
dc.date.accessioned2013-10-18T01:37:32Z-
dc.date.available2013-10-18T01:37:32Z-
dc.date.issued2013-11-01-
dc.identifier.issn1873-9946-
dc.identifier.urihttp://hdl.handle.net/2433/179280-
dc.description.abstract[Background and aim]Cytomegalovirus (CMV) exacerbates ulcerative colitis (UC) refractory to immunosuppressive therapies. The conditions under which CMV reactivation occurs in patients with UC, however, is unclear. In addition, the diagnostic and treatment strategies for UC positive for CMV have not been established. Granulocyte and monocyte adsorptive apheresis (GMAA) is natural biological therapy for UC in which the granulocytes/macrophages producing inflammatory cytokines are removed. We investigated the rate of colonic CMV reactivation and the efficacy of GMAA in active UC patients positive for CMV without concomitant corticosteroid (CS) therapy. [Methods]Fifty-one active UC patients without concomitant CS therapy were enrolled. Colonic CMV reactivation was examined by real-time polymerase chain reaction (PCR) using biopsy specimen and/or histological examination. All patients were treated with intensive GMAA (twice per week). Rates of clinical remission and mucosal healing were compared between UC patients positive and negative for CMV. [Results]Of 51 patients, 15 (29.4%) were diagnosed as CMV positive. The clinical remission rates following intensive GMAA did not differ between UC patients positive and negative for CMV (73.3% vs 69.4%, p = 0.781). Proportion of patients achieving mucosal healing was also similar between these two groups. CMV-DNA became negative in all UC patients positive for CMV who achieved clinical remission 1 week after completion of intensive GMAA. [Conclusions]Intestinal inflammation might trigger CMV reactivation in a subpopulation of active UC patients without CS treatment. GMAA could be a promising option for active UC positive for CMV.en
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier B.V.en
dc.rights© 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V.en
dc.rightsこの論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。ja
dc.rightsThis is not the published version. Please cite only the published version.en
dc.subjectUlcerative colitisen
dc.subjectGranulocyte and monocyte adsorptive apheresisen
dc.subjectCytomegalovirusen
dc.titleEffect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.en
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleJournal of Crohn's & colitisen
dc.identifier.volume7-
dc.identifier.issue10-
dc.identifier.spage803-
dc.identifier.epage811-
dc.relation.doi10.1016/j.crohns.2012.12.003-
dc.textversionauthor-
dc.identifier.pmid23352104-
dcterms.accessRightsopen access-
Appears in Collections:Journal Articles

Show simple item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.